A carregar...
Low dose of azathioprine is effective to induce and maintain remission in active Crohn disease: A prospective observational study
Azathioprine (AZA) 2 to 2.5 mg/kg/d is recommended for European patients with Crohn disease (CD), but several Asian studies reported that low dose of AZA was also effective to treat CD. To confirm those observations, we perform this prospective observational study to compare the efficacy and safety...
Na minha lista:
| Publicado no: | Medicine (Baltimore) |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer Health
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6112906/ https://ncbi.nlm.nih.gov/pubmed/30142769 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000011814 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|